Laurence Tam
Stock Analyst at Morgan Stanley
(0.90)
# 3,732
Out of 4,407 analysts
37
Total ratings
45.8%
Success rate
-4.6%
Average return
Main Sectors:
Stocks Rated by Laurence Tam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $50.00 | $31.06 | +60.98% | 8 | Jun 8, 2026 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Maintained: Hold | $120.00 | $90.00 | +33.33% | 1 | Apr 15, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Maintained: Buy | $60.00 → $88.00 | $48.76 | +80.48% | 2 | Nov 21, 2025 | |
| HKG: 0570 China Traditional Chinese Medicine Holdings Co. Limited | Maintained: Sell | $1.60 | $1.48 | +8.11% | 7 | Oct 17, 2025 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Maintained: Buy | $25.00 → $22.50 | $16.90 | +33.14% | 4 | Aug 22, 2025 | |
| HKG: 3880 Medtide Inc. | Initiated Coverage: Hold | $38.00 | $22.74 | +67.11% | 1 | Aug 6, 2025 | |
| HKG: 0874 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Maintained: Hold | $21.70 → $21.40 | $15.26 | n/a | 4 | Dec 23, 2024 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Maintained: Buy | $17.50 → $17.00 | $11.99 | n/a | 3 | Dec 23, 2024 | |
| HKG: 3320 China Resources Pharmaceutical Group Limited | Maintained: Buy | $7.80 → $7.50 | $4.77 | n/a | 3 | Sep 17, 2024 | |
| HKG: 9989 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Maintained: Hold | $3.50 | $3.99 | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.10 | $3.56 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17.00 → $15.00 | $6.75 | n/a | 2 | Mar 15, 2024 |
WuXi Biologics (Cayman) Inc.
Jun 8, 2026
Maintained: Buy
Price Target: $50.00
Current: $31.06
Upside: +60.98%
Asymchem Laboratories (Tianjin) Co., Ltd.
Apr 15, 2026
Maintained: Hold
Price Target: $120.00
Current: $90.00
Upside: +33.33%
WuXi XDC Cayman Inc.
Nov 21, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $48.76
Upside: +80.48%
China Traditional Chinese Medicine Holdings Co. Limited
Oct 17, 2025
Maintained: Sell
Price Target: $1.60
Current: $1.48
Upside: +8.11%
Sinopharm Group Co. Ltd.
Aug 22, 2025
Maintained: Buy
Price Target: $25.00 → $22.50
Current: $16.90
Upside: +33.14%
Medtide Inc.
Aug 6, 2025
Initiated Coverage: Hold
Price Target: $38.00
Current: $22.74
Upside: +67.11%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Dec 23, 2024
Maintained: Hold
Price Target: $21.70 → $21.40
Current: $15.26
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Dec 23, 2024
Maintained: Buy
Price Target: $17.50 → $17.00
Current: $11.99
Upside: n/a
China Resources Pharmaceutical Group Limited
Sep 17, 2024
Maintained: Buy
Price Target: $7.80 → $7.50
Current: $4.77
Upside: n/a
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Sep 17, 2024
Maintained: Hold
Price Target: $3.50
Current: $3.99
Upside: n/a
Apr 17, 2024
Maintained: Hold
Price Target: $6.10
Current: $3.56
Upside: n/a
Mar 15, 2024
Maintained: Buy
Price Target: $17.00 → $15.00
Current: $6.75
Upside: n/a